enVVeno Medical (NVNO) Liabilities and Shareholders Equity (2017 - 2026)
enVVeno Medical (NVNO) posted quarterly Liabilities and Shareholders Equity of $22.7 million for Q2 2026, down 38.05% year-over-year from $36.6 million in Q2 2025, and down 13.17% quarter-over-quarter from $26.1 million in Q1 2026.
enVVeno Medical (NVNO) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
enVVeno Medical's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $22.7 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 38.05% year-over-year to $22.7 million; the TTM figure through Jun 2026 stood at $110.7 million (down 35.84% YoY), while the FY2025 annual figure was $29.6 million, down 34.24% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $22.7 million, down from $26.1 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $54.2 million in Q1 2022, with the low at $22.7 million in Q2 2026.
- The 5-year median for Liabilities and Shareholders Equity is $40.8 million (2024), against an average of $39.2 million.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity plunged 38.2% in 2023, then soared 79.36% in 2024.
- enVVeno Medical's Liabilities and Shareholders Equity stood at $41.7 million in 2022, then grew by 16.74% to $48.6 million in 2023, then retreated by 7.57% to $45.0 million in 2024, then slumped by 34.24% to $29.6 million in 2025, then decreased by 23.35% to $22.7 million in 2026.
- Business Quant data shows NVNO's Liabilities and Shareholders Equity at $22.7 million in Q2 2026, $26.1 million in Q1 2026, and $29.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 10.74 Bn |
| 10 | enVVeno Medical | 7.12 Mn | 7.12 Mn | - | 22.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.66 Mn |
| Mar 31, 2026 | 26.10 Mn |
| Dec 31, 2025 | 29.56 Mn |
| Sep 30, 2025 | 32.35 Mn |
| Jun 30, 2025 | 36.58 Mn |
| Mar 31, 2025 | 40.58 Mn |
| Dec 31, 2024 | 44.95 Mn |
| Sep 30, 2024 | 50.39 Mn |
| Jun 30, 2024 | 41.00 Mn |
| Mar 31, 2024 | 44.83 Mn |
| Dec 31, 2023 | 48.64 Mn |
| Sep 30, 2023 | 28.09 Mn |
| Jun 30, 2023 | 32.09 Mn |
| Mar 31, 2023 | 36.61 Mn |
| Dec 31, 2022 | 41.66 Mn |
| Sep 30, 2022 | 45.46 Mn |
| Jun 30, 2022 | 49.93 Mn |
| Mar 31, 2022 | 54.22 Mn |
| Dec 31, 2021 | 57.70 Mn |
| Sep 30, 2021 | 59.17 Mn |